SCINAI IMMUNOTHERAPEUTICS LTD. Net Income (Loss) Available to Common Stockholders, Diluted
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Net Income (Loss) Available to Common Stockholders, Diluted of $4.48 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-09.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2024-09-09
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|
| 2024-06-30 | $4.48M 6-K · filed 2024-09-09 | |
| 2023-12-31 | $6.42M 20-F · filed 2024-05-15 | |
| 2023-06-30 | $7.28M 6-K · filed 2024-09-09 | |
| 2022-12-31 | $5.80M 20-F · filed 2024-05-15 | |
| 2021-12-31 | $8.21M 20-F · filed 2024-05-15 |